banner ad
banner ad

Aesthetic Medicine / MediSpa News

Demand For Cosmetic And Surgical Procedures In Dermatologic Surgery Rising Rapidly

November 4, 2009 | 0

ScienceDaily (Oct. 5, 2009) — Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. The number of cosmetic and non-cosmetic surgical procedures […]

Read More

SPASHAPE© Designing Future in Body Contouring Technology

November 2, 2009 | 0

Available since mid 2009, SPASHAPE© combines Scanning Diodes 635mn laser therapy with Second generation of High Focalised Ultrasounds ( Dynamic HFU). Based on 7 years experiences in body contouring innovation, such as ULTRACONTOUR, Medixsysteme, France developed a system that proposed two technologies in one platform. The technology is covered by an international patent. Medixsysteme is […]

Read More

DIY Botox: Site Offers Injectable Drug Without Prescription — With How-To Video

November 2, 2009 | 2

A website that sells a prescription drug similar to Botox without requiring a prescription claims it has more than 2,000 customers. Some have learned how to inject the botulism-derived drug into their own faces from YouTube videos produced for the site. Discountmedspa sells a variety of other DIY cosmetic treatments, including prescription Renova, and lip-filling […]

Read More

Dermaxin Wowing Consumers with Natural Collagen Delivery System

November 2, 2009 | 0

Dermaxin, the world’s leading anti-wrinkle cream, is still dominating the marketplace because it offers a proven, all-natural collagen delivery system that shows results within the first ten minutes of application, and most people will see an overall wrinkle depth reduction of up to 44% within the first 4-12 weeks of daily usage. When compared to […]

Read More

Critics take a dim view of ads for eyelash enhancer

November 2, 2009 | 0

In December, the Food and Drug Administration approved Latisse to treat “hypotrichosis,” a disease of deficient eyelashes. But Allergan Inc. advertised Latisse as “an historic innovation in eyelash enhancement.” At least, it did until the FDA made the company correct its “misleading” promotions and stop omitting risks. Now, ads for the prescription drug warn that […]

Read More

Experts Say Botox Has Potential to Lift Breasts Without Surgery

October 30, 2009 | 0

Oct. 26, 2009 — Add breast lifts to the growing list of potential uses for Botox. But not all experts think it’s worth the trouble. We already know that this wrinkle eraser can help treat excessive sweating, banish frown lines, and put the brakes on certain eye muscle problems and neck spasms. But it may […]

Read More

New technique for injectable facial fillers improves comfort, recovery

October 30, 2009 | 0

DALLAS — Oct. 28, 2009 — Less pain during injections for wrinkle-fighting facial fillers. Less swelling afterward. Less time in the office waiting for anesthesia to take effect. These and other benefits of a new injection technique that UT Southwestern Medical Center plastic surgeons are helping pioneer are outlined in the October issue of Plastic […]

Read More

Botox lawsuit raises issues on injections

October 26, 2009 | 0

Single-use medication vials used on more than one patient. That practice at the Endoscopy Center of Southern Nevada, public health officials have repeatedly said, contributed to the hepatitis C outbreak in the Las Vegas Valley. Now a federal lawsuit filed in California by Las Vegas physician Ivan Goldsmith argues that sales representatives for Allergan Inc., […]

Read More

New Treatment Modality for better dermal remodeling

October 26, 2009 | 0

eMatrix device pioneers Sublative Rejuvenation™ for novel skin ablation and resurfacing Syneron Medical Ltd. (NASDAQ: ELOS), has presented a groundbreaking treatment modality at the 5-Continent-Congress for Lasers and Aesthetic Medicine in Nice on September 10th, 2009. The company introduced a new and unique treatment modality called Sublative Rejuvenation™, which answers the skin rejuvenation market’s emerging […]

Read More

KYTHERA BIOPHARMACEUTICALS PRESENTS POSITIVE DATA FROM TWO PHASE 2 STUDIES WITH ATX-101 – Study results demonstrated statistically significant reduction in patients’ unwanted submental fat

October 26, 2009 | 0

KYTHERA Biopharmaceuticals, Inc. (KYTHERA) presented detailed results from two double-blind Phase 2 studies, each designed to evaluate the safety and effectiveness of ATX-101, a first-in-class injectable drug for the reduction of small volumes of fat. Top-line results from these studies, which examined use of ATX-101 for reduction of unwanted localized fat deposits under the chin […]

Read More

banner ad
banner ad